Benjamin Lee

Professor, Urology | Department Chair, Urology | Director, GU Cancer - Disease Oriented Strategic Planning Team | Member of the Graduate Faculty

College of Medicine - Tucson

Map Page

About

Dr. Lee has participated in multiple clinical trials and is the author or co-author of more than 250 manuscripts, book chapters, and educational teaching videos. He was instrumental in developing a multidisciplinary nanotechnology research program that includes the integration of urology, biomedical engineering, biomolecular engineering, pathology, and physics and materials engineering.

Targeting Lysosomal Vulnerabilities in Renal Pathogenesis
Active·2022·$14.1K / $1.4M·
External
Co-Investigator (COI)
lysosomes, renal disease, pathogenesis, therapeutics, drug discovery
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer
Active·2021·$93.8K / $1.9M·
External
Co-Investigator (COI)
cancer, bioengineering, prostate, mechanisms, stromal dysregulation
Abdominal Adiposity in Early-Onset and Aggressive Clear Cell Renal Cell Carcinoma and Health Disparities
Active·2021·$43.3K / $865.5K·
External
Co-Investigator (COI)
cancer, obesity, health disparities, renal cell carcinoma, adiposity
A Mixed Method to Identify Causes of Kidney Cancer Surgical Disparities in Arizona
2020·$19.4K / $388.5K·
External
Co-Investigator (COI)
cancer, surgery, disparities, mixed methods, kidney
A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence Of Major Adverse Cardiovascular Events (MACEs) in Patients with Prostate Cancer And Cardiovascular Disease...
2019·$238.9K·
External
Principal Investigator (PI)
oncology, cardiovascular, clinical trial, cancer, randomized trial

Page 1 of 2

Recent

Tuberous Sclerosis Complex TSC) Identified by Genetic Testing After Histologic Diagnosis of Chromophobe Renal Cell Carcinoma

2024

genetic testing, renal cell carcinoma, tuberous sclerosis complex, histologic diagnosis, genetic identification

Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era

2023

bladder cancer, chemotherapy, drug shortage, treatment

Digital Image analysis using Video microscopy of human-derived prostate cancer vs normaprostate organoids to assess migratory behavior on extracellular matrix proteins.

2023

digital image analysis, video microscopy, prostate cancer, organoid research, extracellular matrix

Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity

2023

neddylation, cisplatin, nephrotoxicity, targeted therapy, drug-induced toxicity

A Typical Progression Pattern after Pre-Docetaxel Abiraterone for Metastatic Prostate Cancer: Report of Two Cases

2022

prostate cancer, metastatic, abiraterone, progression pattern, pre-docetaxel

Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins

2022

digital image analysis, prostate cancer, microscopy, organoids, extracellular matrix

Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients

2022

neighborhood characteristics, surgical treatment disparities, overall mortality, stage i renal cell carcinoma, impacts

Page 1 of 8

Ultrasound-guided Percutaneous Nephrostomy Model
2018·Technology

Benjamin Lee

About

Research Area

Grants(7)

Targeting Lysosomal Vulnerabilities in Renal Pathogenesis

Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer

Abdominal Adiposity in Early-Onset and Aggressive Clear Cell Renal Cell Carcinoma and Health Disparities

A Mixed Method to Identify Causes of Kidney Cancer Surgical Disparities in Arizona

A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence Of Major Adverse Cardiovascular Events (MACEs) in Patients with Prostate Cancer And Cardiovascular Disease...

Publications(69)

Tuberous Sclerosis Complex TSC) Identified by Genetic Testing After Histologic Diagnosis of Chromophobe Renal Cell Carcinoma

Neighborhood social vulnerability and disparities in time to kidney cancer surgical treatment and survival in Arizona

AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.

Clear cell renal cell carcinoma molecular variations in non-Hispanic White and Hispanic patients

Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era

Digital Image analysis using Video microscopy of human-derived prostate cancer vs normaprostate organoids to assess migratory behavior on extracellular matrix proteins.

Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity

A Typical Progression Pattern after Pre-Docetaxel Abiraterone for Metastatic Prostate Cancer: Report of Two Cases

Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins

Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients

Collaborations(40)

Andrew Rouse

Anne Cress

Megha Padi

Patrick Wightman

Ritu Pandey

Techs/Patents(1)

Ultrasound-guided Percutaneous Nephrostomy Model